NCT04215588View on ClinicalTrials.gov

Heparin and Protamine Titration in Cardiac Surgery Under Minimal Invasive Extracorporeal Circulation

NACompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

September 30, 2022

Conditions

Cardiopulmonary Bypass

Interventions

DEVICE

Hemostasis Management System Plus

Hemostasis Management System Plus (Medtronic, Minneapolis, MN) is a point of care device useful in the management of heparinization during bypass. It estimates the individual heparin dose response and calculates heparin concentration (IU/ml) in whole blood.

DEVICE

Activated Coagulation Timer System Plus

The Activated Coagulation Timer System Plus device calculates the Activated Clotting Time (ACT) in seconds.

Trial Locations (1)

Unknown

Aristotle University of Thessaloniki, Thessaloniki

All Listed Sponsors

lead

Aristotle University Of Thessaloniki

OTHER

NCT04215588 - Heparin and Protamine Titration in Cardiac Surgery Under Minimal Invasive Extracorporeal Circulation | Biotech Hunter | Biotech Hunter